People · Operator

Marcio Aurelio Martins Abreu

Named in public records as an officer, director or promoter · active 2010–2013 · Biotechnology

1
Companies
3
Filings
$46.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Brain Tunnelgenix Technologies CorpBiotechnologySeries B$46.0M$86.5M2010
Operator network

Marcio Aurelio Martins Abreu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Anthony Raymond DeChello · 1 companies · 1 sharedAnthony Raymond D…Joseph Roger Titone · 1 companies · 1 sharedJoseph Roger Tito…Marc Abreu · 1 companies · 1 sharedMarc AbreuMarcio Marc Aurelio Martins Abreu · 1 companies · 1 sharedMarcio Marc Aurel…Maria Allen Altieri · 1 companies · 1 sharedMaria Allen Altie…Maria Aurelio Martins Altieri · 1 companies · 1 sharedMaria Aurelio Mar…Maria J. Altieri · 1 companies · 1 sharedMaria J. AltieriMaria R Altieri · 1 companies · 1 sharedMaria R AltieriPaul Anthony Caiafa · 1 companies · 1 sharedPaul Anthony Caia…Rick Allen Foreman · 1 companies · 1 sharedRick Allen ForemanRobert J. Mogel · 1 companies · 1 sharedRobert J. MogelBrain Tunnelgenix Technologies Corp · $46.0M raisedBrain Tunnelgenix Tec…Marcio Aurelio Martins AbreuMA
Marcio Aurelio Martins Abreu Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Marcio Aurelio Martins Abreu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Rick Allen Foreman11
Maria Allen Altieri11
Joseph Roger Titone11
Paul Anthony Caiafa11
Anthony Raymond DeChello11
Maria Aurelio Martins Altieri11
Maria R Altieri11
Marcio Marc Aurelio Martins Abreu11
Maria J. Altieri11
Robert J. Mogel11
Marc Abreu11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.